BridgeMD
New treatment option for Pre Diabetes
Official title Preventing Diabetes: Impact of an EMR-Based Intervention for Enhanced Pre-Diabetes Management in Primary Care
ClinicalTrials.gov ID: NCT07252700
What this study is testing
- What it's testing
- The goal of this study is to find out if adding electronic medical record (EMR) prompts helps prevent people with pre-diabetes from developing diabetes. It will also look at how these prompts affect doctor and patient behaviors.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 59
You may be able to join if
- for study population (EMR based analytic cohort):
- All adults aged 21 to 59 years with prediabetes who attend any of the eight participating polyclinics during the study period will be included in the...
- Prediabetes is defined as impaired fasting glucose or impaired glucose tolerance according to standard clinical criteria, with either diagnosis...
- Individuals with a prior diagnosis of diabetes will be excluded. for patient surveys:
- Adults aged 40-59 years
You likely can't join if
- for patient surveys:
- Prior diagnosis of diabetes mellitus or gestational diabetes
- Severe acute or chronic liver or kidney disease
- Pregnancy
- Cognitive impairment
- Inability to communicate in English Inclusion Criteria for clinician surveys:
See the full eligibility criteria
- for study population (EMR based analytic cohort):
- All adults aged 21 to 59 years with prediabetes who attend any of the eight participating polyclinics during the study period will be included in the EMR-based analytic cohort.
- Prediabetes is defined as impaired fasting glucose or impaired glucose tolerance according to standard clinical criteria, with either diagnosis documented in the EMR problem list or visit diagnosis.
- Individuals with a prior diagnosis of diabetes will be excluded. for patient surveys:
- Adults aged 40-59 years
- Diagnosed with prediabetes (impaired fasting glucose or impaired glucose tolerance)
- Receiving routine follow-up care at NUP polyclinics
- Able to provide written informed consent
- Able to complete questionnaires in English
- for patient surveys:
- Prior diagnosis of diabetes mellitus or gestational diabetes
- Severe acute or chronic liver or kidney disease
- Pregnancy
- Cognitive impairment
- Inability to communicate in English Inclusion Criteria for clinician surveys:
- All clinicians that consult patients in National University Polyclinics
- No exclusion criteria specified for clinicians
The study team makes the final eligibility decision.
Where it's taking place
- Singapore, Singapore
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 59 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Singapore, Singapore. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.